1. Repository of OAI
Ελληνικά   English  

Browsing by Author Tselepis, A. D.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 131 to 150 of 255 < previous   next >
TitleAuthor(s)Issue date???itemlist.???
Implication of lipoprotein associated phospholipase A(2) activity in oxLDL uptake by macrophagesMarkakis, K. P.; Koropouli, M. K.; Grammenou-Savvoglou, S.; van Winden, E. C.; Dimitriou, A. A.; Demopoulos, C. A.; Tselepis, A. D.; Kotsifaki, E. E.24-Nov-2015-
Increased activity of platelet-activating factor acetylhydrolase in low-density lipoprotein subfractions induces enhanced lysophosphatidylcholine production during oxidation in patients with heterozygous familial hypercholesterolaemiaKarabina, S. A. P.; Elisaf, M.; Bairaktari, E.; Tzallas, C.; Siamopoulos, K. C.; Tselepis, A. D.24-Nov-2015-
Increased activity of platelet-activating factor acetylhydrolase in low-density lipoprotein subfractions induces enhanced lysophosphatidylcholine production during oxidation in patients with heterozygous familial hypercholesterolaemiaKarabina, S. A.; Elisaf, M. S.; Bairaktari, E.; Tzallas, C.; Siamopoulos, K. C.; Tselepis, A. D.24-Nov-2015-
Increased levels of autoantibodies against copper-oxidized forms of LDL and malondialdehyde-LDL in patients with early rheumatoid arthritisLourida, E. S.; Georgiadis, A.; Voulgari, P.; Drosos, A.; Tselepis, A. D.24-Nov-2015-
Increased plasma levels of visfatin/pre-B cell colony-enhancing factor in obese and overweight patients with metabolic syndromeFilippatos, T. D.; Derdemezis, C. S.; Kiortsis, D. N.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015-
Increased plasma visfatin concentration is a marker of an atherogenic metabolic profileFilippatos, T. D.; Tsimihodimos, V.; Derdemezis, C. S.; Gazi, I. F.; Saougos, V.; Mikhailidis, D. P.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015-
Increased plasma visfatin levels in subjects with the metabolic syndromeFilippatos, T. D.; Derdemezis, C. S.; Gazi, I. F.; Lagos, K.; Kiortsis, D. N.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015-
Increased platelet reactivity to the aggregatory effect of platelet activating factor, in vitro, in patients with heterozygous familial hypercholesterolaemiaElisaf, M.; Karabina, S. A. P.; Bairaktari, E.; Goudevenos, J. A.; Siamopoulos, K. C.; Tselepis, A. D.24-Nov-2015-
Increased platelet reactivity to the aggregatory effect of platelet activating factor, in vitro, in patients with heterozygous familial hypercholesterolaemiaElisaf, M. S.; Karabina, S. A.; Bairaktari, E.; Goudevenos, J. A.; Siamopoulos, K. C.; Tselepis, A. D.24-Nov-2015-
Inflammation, bioactive lipids and atherosclerosis: potential roles of a lipoprotein-associated phospholipase A2, platelet activating factor-acetylhydrolaseTselepis, A. D.; Chapman, M. J.24-Nov-2015-
The inflammatory state in active juvenile rheumatoid arthritis is associated with hypo HDL-EMIA and reduced lipoprotein-associated PAF-acetylhydrolase activityTselepis, A. D.; Elisaf, M. S.; Besis, S.; Karabina, S. A. P.; Chapman, M. J.; Siamopoulou, A.24-Nov-2015-
Influence of high-density lipoprotein and paraoxonase-1 on platelet reactivity in patients with acute coronary syndromes receiving clopidogrel therapyTselepis, A. D.; Tsoumani, M. E.; Kalantzi, K. I.; Dimitriou, A. A.; Tellis, C.; Goudevenos, I. A.24-Nov-2015-
Influence of high-density lipoprotein and paraoxonase-1 on platelet reactivity in patients with acute coronary syndromes receiving clopidogrel therapyTselepis, A. D.; Tsoumani, M. E.; Kalantzi, K. I.; Dimitriou, A. A.; Tellis, C. C.; Goudevenos, I. A.24-Nov-2015-
The influence of serum apolipoprotein E concentration and polymorphism on serum lipid parameters in hemodialysis patientsLiberopoulos, E. N.; Miltiadous, G. A.; Cariolou, M.; Tselepis, A. D.; Siamopoulos, K. C.; Elisaf, M. S.24-Nov-2015-
Inhibition by Cardiolipins of Platelet-Activating Factor-Induced Rabbit Platelet ActivationTsoukatos, D.; Demopoulos, C. A.; Tselepis, A. D.; Moschidis, M. C.; Donos, A.; Evangelou, A.; Benveniste, J.24-Nov-2015-
Inhibition of platelet activation and fibrinogen binding to alpha(IIb)beta(3) using synthetic peptide-analogues derived from the beta(3) subunit: A comparative studyTselepis, A. D.; Rodi, F. I.; Mitsios, J. V.; Stathopoulos, P.; Sakarellos-Daitsiotis, M.; Sakarellos, C.; Michalis, L. K.; Goudevenos, J. A.; Elisaf, M.; Tsoukatos, D.; Tsikaris, V.; Sideris, D. A.24-Nov-2015-
Inhibition of platelet activation by peptide analogs of the beta(3)-intracellular domain of platelet integrin alpha(IIb)beta(3) conjugated to the cell-penetrating peptide Tat(48-60)Dimitriou, A. A.; Stathopoulos, P.; Mitsios, J. V.; Sakarellos-Daitsiotis, M.; Goudevenos, J.; Tsikaris, V.; Tselepis, A. D.24-Nov-2015-
Inhibition of platelet activation by peptide analogues of the intracellular domain of beta 3 subunit of the platelet integrin receptorDimitiou, A. A.; Stathopoulos, P.; Tsikaris, B.; Tselepis, A. D.24-Nov-2015-
Inhibitory Effects of Synthetic Peptide Analogues of the Human Platelet Integrin Alphaiibeta Subunit on Rabbit Platelet AggregationStathopoulou, E. M.; Roufou, C. E.; Koloka, V. N.; Tellis, C. C.; Sakarellos, C.; Sakarellos, M.; Tsikaris, V.; Tselepis, A. D.24-Nov-2015-
The inhibitory potency of clopidogrel on ADP-induced platelet activation is not attenuated when it is co-administered with atorvastatin (20 mg/day) for 5 weeks in patients with acute coronary syndromesMitsios, J. V.; Papathanasiou, A. I.; Elisaf, M. S.; Goudevenos, J. A.; Tselepis, A. D.24-Nov-2015-
Showing results 131 to 150 of 255 < previous   next >